glp 1 drugs alzheimer's Details of failed studies cast pall on Novo Nordisk's GLP-1 as treatment Potential mechanisms of anti-diabetic drugs

Now Pfizers public declaration that its at the end of the beginning in entering the GLP1 market marks a pivotal

Our blog series on GLP-1 agonists for weight loss is aimed at unpacking the science behind this new frontier in weight management, presenting a detailed overview of how they work, their efficacy, and their role in a holistic approach to health and wellness.

Clinical Frameworks: Defining Obesity Beyond Body Mass Index (BMI) An important milestone of 2025 was the publication of The Lancet Diabetes & Endocrinology Commission on the Definition and Diagnostic Criteria of Clinical Obesity

Discover if Zepbound is the right treatment for you.

Does GLP-1 help with depression